We have outstanding technological innovation capabilities and the ability to provide customers with overall solutions for Parsabiv injection, Diquafosol Sodium Medicine Eye Drops, Sitafloxacin Oral Tablets. Our company's products have won the favor of the market and customers by virtue of excellent product quality and efficient after-sales service, and are sold at home and abroad. We are gradually becoming a competitive enterprise in the Diquafosol Sodium Eye Drops industry. The development and application of high and new technology has brought us the possibility of obtaining high profit margin. Our focus on the latest industry trends enables us to provide innovative solutions to complex challenges. We are committed to maximizing customer satisfaction and growing the enterprise and employees together. Welcome all prospects of residence and abroad to visit our organization, to forge a outstanding potential by our cooperation. Our strict attention to detail and superior quality are the essence of our company.
-
![Diquafosol Sodium Eye Drops]()
Diquafosol Sodium Eye DropsDiquafosol Sodium Eye Drops are a prescription ophthalmic medicine for dry eye disease that selectively activates P2Y₂ receptors and promotes endogenous secretion of tears and mucin. CASread more -
![Lanreotide Injection]()
Lanreotide InjectionLanreotide Injection is a classic long-acting synthetic polypeptide somatostatin analog worldwide, applied in rare endocrine disease diagnosis and treatment for decades. CASread more -
![Tirzepatide FDA]()
Tirzepatide FDATirzepatide Injection is developed and manufactured by Eli Lilly and Company. As the world’s first GLP-1/GIP dual receptor agonist injection, it has obtained Tirzepatide fda approval and filled gapsread more -
![Semaglutide Injection]()
Semaglutide InjectionSemaglutide Injection (CAS 910463-68-2) is a human glucagon-like peptide-1 (GLP-1) analog produced by recombinant DNA technology using Saccharomyces cerevisiae. CAS Numberread more -
![Liraglutide Injection]()
Liraglutide InjectionLiraglutide Injection (CAS: 204656-20-2) is a human glucagon-like peptide-1 (GLP-1) analog produced by recombinant DNA technology. CAS Number 204656-20-2 Formularead more -
![Linaclotide Capsules]()
Linaclotide CapsulesLinaclotide Capsules are globally recognized first‑line oral peptide formulations targeting guanylate cyclase‑C (GC‑C) receptors. CAS Number 851199-59-2 Formularead more -
![Glatiramer Acetate]()
Glatiramer Acetatelatiramer Acetate Injection is a globally classic immunomodulatory disease-modifying therapy (DMT) injection for multiple sclerosis (MS). CAS Number 147245-92-9 Formularead more -
![Atosiban Acetate Injection]()
Atosiban Acetate InjectionAtosiban Acetate Injection is a first-line highly selective oxytocin/vasopressin V1A receptor antagonist in clinical practice. CAS Number 90779-69-4 Formularead more -
![Vortioxetine Hydrobromide Tablets]()
Vortioxetine Hydrobromide TabletsVortioxetine Hydrobromide Tablets are a new-generation multi-target 5 hydroxytryptamine modulator oral antidepressant with dual effects of antidepressant and cognitive improvement. CASread more -
![Propofol Medium and Long Chain Fat Emulsion Injection]()
Propofol Medium and Long Chain Fat Emulsion InjectionPropofol Medium and Long Chain Fat Emulsion Injection is a first-line short-acting intravenous general anesthetic and sedative agent in clinical practice. Adopting a combined medium-chain/long-chainread more -
![Dexmedetomidine Hydrochloride Injection]()
Dexmedetomidine Hydrochloride InjectionDexmedetomidine HCl Injection is a highly selective α₂-adrenergic receptor agonist for intravenous sedation. As a core sedative in perioperative and intensive care settings, it features uniqueread more -
![Sitafloxacin Tablets]()
Sitafloxacin TabletsTamoxifen Citrate Powder (CAS 54965-24-1) is one of the most widely used and longest-established anti-estrogen antitumor raw materials in global clinical practice, especially effective on theread more
Juan Cabana
This product is the company's new blockbuster. On the basis of the original product, the product has added more functions, and the shell material has also been upgraded to a more environmentally
Mckinley Sligh
I think this brand product is very good and worth recommending.
Royal Wagner
We are very satisfied that the goods you delivered were not damaged in transit.
Natividad Quinones
Cooperating with this manufacturer has relieved us of a lot of troubles and pressures in this procurement process, and has also been well received by our leaders and customers.
Chris Caraballo
Although you are a century old enterprise, you have the most advanced ideas, and can constantly learn to develop the latest products.
Terry Giles
After this purchase, we have added this company to our priority cooperation list, and it is really a pleasure to cooperate with them.
Effect of topical 3% diquafosol sodium on eyes with dry eye …...
This study examined the effect of 3% diquafosol sodium ophthalmic solution on the signs and symptoms of dry eye disease in eyes with MGD. The number of telangiectasia and plugged...
Diquafosol Sodium Eye Drop - HealthHub...
Jun 22, 2023 · Diquafosol sodium is used to improve symptoms of dry eyes. It increases tear fluid and mucin secretions in the eyes. How should I take or use this medication? Proper use of eye...
3% diquafosol sodium eye drops in Chinese patients …...
May 24, 2023 · Therefore, 3% diquafosol sodium eye drops can significantly reduce corneal fluorescein staining. A phase III clinical trial jointly conducted in China and Singapore compared the...
Diquas - Santen Asia...
Diquas® is a product that contains diquafosol sodium, a substance that stimulates tear and mucin secretion in the eyes. It is indicated for dry eye patients with keratoconjunctival epithelium...
Clinical utility of 3% diquafosol ophthalmic solution in the …...
It also introduces the additive effect of diquafosol on sodium hyaluronate monotherapy for dry eye, and the effect of 3% diquafosol ophthalmic solution for dry eye-related conditions. Additionally,...
Diquafosol ophthalmic solution 3 %: a review of its use in dry eye...
Diquafosol ophthalmic solution 3 % (Diquas(®)) is a P2Y2 receptor agonist that promotes tear fluid and mucin secretion and is currently approved in Japan and South Korea for the treatment of dry eye....
We are constantly looking to improve in all areas and to expand and broaden our existing Vortioxetine Hydrobromide Tablets, Cagrilintide and Semaglutide, Levodopa API lines and services. HK Neopharm Limited is one of the most professional diquafosol sodium eye drops manufacturers and suppliers in China, also supports customized service. Welcome to buy high quality diquafosol sodium eye drops in stock here and get quotation from our factory. For price consultation, contact us.
Send Inquiry